Trial intelligence / Profile preview

Enzira influenza vaccine immunogenicity and safety study in healthy adults and older adults (2007/2008 season)

2007-001465-14Phase 4Completed

Sponsor
CSL Limited
Start
Mar 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of omeprazole in influenza (2 arms), sponsored by CSL Limited. Primary endpoint: Immunogenicity by CPMP criteria. Started Mar 2007; status: completed.

02

Drugs

omeprazole
03

Conditions

influenza

Beyond the preview

Go deeper on 2007-001465-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001465-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call